Ethics and Multidrug Resistant Latent TB
Updated: Dec 4, 2020
Should preventative therapy be given to patients with latent multidrug resistant TB?
Authors Binh Nguyen, Greg Fox, Paul Mason, and Justin Denholm present a thoughtful and nuanced assessment of the ethical landscape of expanding access to preventative therapies for multidrug resistant TB.
The discussion draws on TB-CRE investigator's programmatic engagement in Vietnam, and considers a breadth of factors including the impact of social norms and expectations, economic concerns, evidentiary burden, the onus to protect the most vulnerable (and disproportionately effected) members of society, and appeal to action in light of harm and its moral significance.